Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-002002-43Phase 4Terminated
Phase 4, randomised, open-label trial of erythromycin, neomycin, sodium picosulfate, magnesium oxide and citric acid in surgical site infection (SSI) (3 arms), sponsored by IIS Aragón. Primary endpoints: Temperature and Surgical site infection incidence. Started Oct 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-002002-43.